• Presented at UEG Week (2021)

  • Collaborator: Takeda

  • Authors: Gionata Fiorino, Nawal Bent-Ennakhil, Pasquale Varriale, Fiona Braegger, Eveline Hoefkens

Inflammatory bowel disease, comprising Crohn’s disease and ulcerative colitis poses a
substantial burden on patient and healthcare systems. Understanding patient preferences
through shared decision-making optimizes treatment acceptance and adherence. Discrete choice
experiments (DCEs) elicit multi-attribute preferences, thereby quantifying the strength of each
preference for healthcare interventions.

Objective: The present study aims to explore patients’ preferences for treatment attributes of the
currently available advanced therapies.